Escitalopram-Induced Hyponatremia and Neurological Adverse Effects: A Case Series
Escitalopram is a Selective Serotonin Receptor Inhibitor (SSRI) prescribed for the management of anxiety, major depressive disorders, agitation, and dementia. Hyponatremia is a familiar side effect of SSRIs; however, there are only a few pieces of literature that give evidence of escitalopram-induced hyponatremia and hyponatremic encephalopathy. SSRIs are also known to cause rare neurological side effects, such as extrapyramidal symptoms like tremulousness, Parkinsonism, which often go unlisted. SSRIs also shows an example of drug-induced psychiatric disorders such as visual hallucinations.
Authors
- S Harikrishnan (ORCID: https://orcid.org/0000-0002-7509-0712)
- Keshav J. Kumar
- J. R.
- CHRISTEENA MARY VIJI
- Merin.V. Jolly
Institutions
- Nazareth College (US)
- Government Medical College and Hospital (IN)
- Indian Institute of Technology Palakkad (IN)
- Third Hospital of Changsha (CN)
Publication Details
- Journal
- International Journal of Research in Pharmacology & Pharmacotherapeutics
- Published
- 2025-03-04
- DOI
- https://doi.org/10.61096/ijrpp.v14.iss1.2025.161-166
- Primary Topic
- Electroconvulsive Therapy Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00